Industry reacts to TGA down-scheduling decision with cautious optimism by Martin Lane December 17, 2020December 17, 2020 The industry has broadly welcomed the Therapeutic Goods Administration’s decision to down schedule low-dose CBD – […]
Investors still attracted to low-cost, high-margin cannabis businesses by Martin Lane August 11, 2020August 14, 2020
